Category: Prescriptions for Policy

[Forum] [Spotlight] [Commentary] [Research] [Events] [News]

• To Err is Human, To Sue Routine. By Paul Howard, January 11, 2008
• It's Just Improper By Benjamin Zycher, January 09, 2008
• Who'd A Thunk It? By Benjamin Zycher, January 07, 2008
• Caffeine, News, and Commentary By Paul Howard, January 07, 2008
• Marketing = Bad? By Paul Howard, January 04, 2008
• It's Not Good To Be Poor By Benjamin Zycher, January 02, 2008
• Zero Tolerance for Risk Means Zero Innovation By Paul Howard, January 02, 2008
• Troubling Developments in Med Mal Lawsuits. By Paul Howard, December 21, 2007
• Cancer and the Uninsured By Paul Howard, December 20, 2007
• Mass Connector: Insurance without Access? By Paul Howard, December 19, 2007
• Congress Gets Tough on Competition By Paul Howard, December 18, 2007
• The Other "War on Drugs" By Paul Howard, December 17, 2007
• Jeff Sachs Strikes Again By Benjamin Zycher, December 17, 2007
• Moving Standards Hurt Patients, Slow Innovation By Paul Howard, December 14, 2007
• D.C. City Council Confuses Drug Industry with Pinata By Paul Howard, December 12, 2007
• As I Was Saying... By Benjamin Zycher, December 12, 2007
• A Word About "Authorized" Generics By Benjamin Zycher, December 12, 2007
• Super-Sized Stupidity, Beltway-Style By Benjamin Zycher, December 10, 2007
• Hearken Sinners: The End Is Near By Benjamin Zycher, December 06, 2007
• Is Big Pharma headed for a big fall? By Paul Howard, December 06, 2007
• Employees told to skip that twinkee. By Paul Howard, December 05, 2007
• Evil insurers or careless math? By Paul Howard, December 04, 2007
• Clash of the (Health Care) Titans By Paul Howard, December 03, 2007
• Safer than what? By Paul Howard, November 27, 2007
• Risk Averse Regulators By Paul Howard, November 20, 2007
• Has Merck Turned the Corner on Vioxx? By Paul Howard, November 12, 2007
• Krugman's Grain of Truth By Paul Howard, November 09, 2007
• UK's Bad Medicine By Paul Howard, November 05, 2007
• An Offer You Can't Refuse. By Paul Howard, November 02, 2007
• U.S. v. U.K. on Cancer Care By Paul Howard, November 01, 2007
• Headlines Galore. By Paul Howard, October 29, 2007
• They do it in Europe. By Paul Howard, October 26, 2007
• Competition Works. By Paul Howard, October 26, 2007
• Fetal Monitors and Litigation: Chicken or Egg? By Paul Howard, October 26, 2007
• Evil and All-Powerful Companies. Except for the markets. By Paul Howard, October 23, 2007
• Pre-Paid Primary Care By Paul Howard, October 22, 2007
• Parents, Vaccines, and Fear. By Paul Howard, October 19, 2007
• Yes, but it's still free. By Paul Howard, October 18, 2007
• Congress Plays Doctor All the Time. By Paul Howard, October 18, 2007
• Marginal Revolution Takes on Health Care By Paul Howard, October 17, 2007
• A Little Self Dealing. By Paul Howard, October 17, 2007
• Yes, but it's free. By Paul Howard, October 15, 2007
• Waiting, Canadian style. (But at least it's universal. Or is it?) By Paul Howard, October 15, 2007
• Book Review on "Overtreated" By Paul Howard, October 12, 2007
• Genentech (Lucentis) v. Genentech (Avastin) By Paul Howard, October 12, 2007
• This Changes Everything. Maybe. By Paul Howard, October 05, 2007
• Healthy Competition: Branded v. Generic Drugs By Paul Howard, October 05, 2007
• Teeing Up An SCHIP Veto By Paul Howard, October 03, 2007
• Ezra Klein's Feeling Blue By Paul Howard, October 01, 2007
• FDA Reform: Two Steps Forward, Three Steps Back? By Paul Howard, September 28, 2007
• The Competition Solution for Health Care By Paul Howard, September 20, 2007
• Plaintiff's Lawyers Attack FDA Authority By Paul Howard, September 20, 2007
• Romney Refutes HillaryCare By Paul Howard, September 20, 2007
• Universal Insurance and Cancer Care By Paul Howard, September 14, 2007
• Moore Deception from Sicko By Paul Howard, September 13, 2007
• Stossel Challenges Moore on Cuban Health Care By Paul Howard, September 11, 2007
• Scared to death? By Paul Howard, September 10, 2007
• Times' Interview with Novartis CEO Daniel Vasella By Paul Howard, September 10, 2007
• New Social Contract? By Paul Howard, September 10, 2007
• A Dangerous Label? By Paul Howard, September 07, 2007
• Mandatory preventive care? By Paul Howard, September 04, 2007
• Doctors to Washington: Your Rules Don't Make Sense By Paul Howard, August 31, 2007
• Care and Credit By Paul Howard, August 30, 2007
• Arnold wrestles with CA health care By Paul Howard, August 30, 2007
• More Transparency Needed in Government Studies By Paul Howard, August 30, 2007
• A new health care fix. By Paul Howard, August 29, 2007
• More Profits = More Innovation By Paul Howard, August 28, 2007
• Romney Unveils Health Care Plan By Paul Howard, August 24, 2007
• Popular retail care clinics? Call in the regulators. By Paul Howard, August 23, 2007
• FDA to patients: Be afraid, be very afraid. By Paul Howard, August 22, 2007
• Canada's Conundrum By Paul Howard, August 20, 2007
• Emily Litella Lives By Benjamin Zycher, August 09, 2007
• SCHIP sails out of the senate. By Paul Howard, August 03, 2007
• Science, Statistics, and Cancer By Paul Howard, August 02, 2007
• Redi and Waiting. By Paul Howard, August 02, 2007
• Too Fast or Too Slow? By Paul Howard, August 01, 2007
• In the Pipeline on Avandia By Paul Howard, August 01, 2007
• More "me too" drugs please. By Paul Howard, July 31, 2007
• All things SCHIP. By Paul Howard, July 31, 2007
• Saint Paul Krugman: Those who disagree with my views on health care are immoral. By Paul Howard, July 30, 2007
• Avandia Hearings at FDA By Paul Howard, July 27, 2007
• No Rest For the Weary By Benjamin Zycher, July 27, 2007
• Patients or Customers? By Paul Howard, July 26, 2007
• The Doctor is Out. By Paul Howard, July 25, 2007
• Pareto's Rule for Chronic Care By Paul Howard, July 24, 2007
• Medicaid Coverage and Health Care Access By Paul Howard, July 20, 2007
• Monty Python Lives By Benjamin Zycher, July 19, 2007
• Fantasies and Fairy Tales? By Paul Howard, July 18, 2007
• The Road to Hell. By Paul Howard, July 17, 2007
• Generics or branded drugs? Let consumers choose. By Paul Howard, July 17, 2007
• Paying for Pills: A New Paradigm? By Paul Howard, July 16, 2007
• Gold Plated SCHIP Ready to Set Sail By Paul Howard, July 13, 2007
• Familiarity and Contempt - for Lifesaving Medicines By Paul Howard, July 13, 2007
• Insurance and Chronic Care By Regina Herzlinger, July 12, 2007
• New Report: Medical Innovation Drives U.S. Longevity Gains By Paul Howard, July 11, 2007
• A Tale of Two Studies By Paul Howard, July 09, 2007
• MTV Reviewer Takes a Scalpel to Sicko By Paul Howard, July 03, 2007
• Lawsuit Lottery By Paul Howard, June 28, 2007
• Health Care and Competition By Paul Howard, June 27, 2007
• Rationing Medical Care a "Necessary Evil" in the UK By Paul Howard, June 27, 2007
• AMA Attacks Convenient Care Clinics By Paul Howard, June 26, 2007
• Shackling Patient Care By Paul Howard, June 22, 2007
• Welcome to the new MPT Forum By Paul Howard, June 22, 2007

• The Medicare Modernization Act 2003 Mark McClellan, July 2004
• Questioning the Evidence in Evidence-Based Guidelines Michael Weber, M.D., July 2004
• Our competitors understand why America is the global leader in biotechnology. Robert Goldberg, Ph.D., April 2005
• Profits and Progress Cannot Be Separated Robert Goldberg, Ph.D., August 2004
• The Stem-Cell Wars Robert Goldberg, Ph.D., August 2004
• Me-too Mythology Robert Goldberg, Ph.D., August 2004
• Prescription Against Medical Terror Robert Goldberg, Ph.D., August 2004
• Britain's National Health Service Embraces a New Faith in Market Incentives Benedict Irvine, September 2004
• European Price Controls Harm Patient Health Robert Goldberg, Ph.D., September 2004
• KerryCare for the Greatest Generation? Robert Goldberg, Ph.D., September 2004
• Does Importation Save Money and Lives? Not in Europe. Robert Goldberg, Ph.D., September 2004
• The rush to black label (or blackball) SSRIs. Sally Satel, MD, September 2004
• Waiting for the 17th plan Jacob Arfwedson, October 2004
• Fantasy’s End. Sally C. Pipes, December 2004
• Christopher Reeve: Action Hero Robert Goldberg, Ph.D., October 2004
• Blame Congress Robert Goldberg, Ph.D., October 2004
• Small Businesses are Saving Money and Insuring More People Today With Health Savings Accounts Newt Gingrich, , Vince Haley, November 2004
• Figuring the Benefits and Risks of Drug Therapy Michael Weber, M.D., November 2004
• Mr. President, stay the course. Robert Goldberg, Ph.D., November 2004
• Don’t Kill The Pharmaceutical Golden Goose Gilbert L. Ross, M.D., November 2004
• Vioxx Backlash Could Derail Future of Medicine Robert Goldberg, Ph.D., , Paul Howard, Ph.D., January 2005
• Innovative approaches to relief Robert Goldberg, Ph.D., January 2005
• A limited solution for a limited problem. Sally C. Pipes, February 2005
• The New Frontier for Drug Safety Gualberto Ruaño, M.D., Ph.D., , Robert Goldberg, Ph.D., February 2005
• Can Free Market Principles Work With Pharmaceutical Price Controls? Benjamin Zycher, Ph.D., March 2005
• The War on Carcinogens vs. The War on Cancer Elizabeth Whelan, March 2005
• The Cost of Germs Betsy McCaughey, March 2005
• Why the new NIH ethics rules are bad for the agency - and the public health. Elizabeth Whelan, April 2005
• Congress is stalling real Medicaid reform. David Gratzer, April 2005
• Death and Taxes. Roger Bate, May 2005
• Faster Cures For the Future Robert Goldberg, Ph.D., May 2005
• The Return of HillaryCare David Gratzer, May 2005
• Cancer patients are paying for the FDA's caution. Dr. Scott Gottlieb, May 2005
• The Vioxx Panic Marc Siegel, MD, June 2005
• Hotel California Health Care Sally C. Pipes, July 2005
• In Pursuit of Fewer Medicines and More Lawsuits Benjamin Zycher, Ph.D., July 2005
• Doctor, spare me the politics - you're making me sick Philip Stevens, August 2005
• Focusing the spotlight on the real Scott Gottlieb Robert Goldberg, Ph.D., September 2005
• Making the perfect the enemy of the good Derek Lowe, September 2005
• New FDA leadership Robert Goldberg, Ph.D., October 2005
• Bare-Knuckle Politics Leads to Bad Public Policy Peter J. Pitts, October 2005
• The Lion and the Lambs Laying Down Together Benjamin Zycher, Ph.D., October 2005
• Head-to-Head Drug Trials at California's Ballot Box John R. Graham, November 2005
• The Acute Nature of Chronic Problems Peter J. Pitts, November 2005
• A Victim of Their Own Devices Peter J. Pitts, December 2005
• Ghostwriters go bump in the medical journals. Peter J. Pitts, December 2005
• Ariel Sharon and Stroke Treatment Marc Siegel, MD, January 2006
• Suicide Risks and SSRIs: New Data Should Change the Equation Sally Satel, MD, January 2006
• Smoking Out Cliches About Race Sally Satel, MD, February 2006
• The Pain Medicines: Another Chapter is Written Michael Weber, M.D., January 2006
• Policy Forum: The State of the Union Health Care Proposals Joseph R. Antos, Ph.D., February 2006
• Policy Forum: The State of the Union Health Care Proposals Benjamin Zycher, Ph.D., February 2006
• Policy Forum: The State of the Union Health Care Proposals James R. Copland, February 2006
• Policy Forum: The State of the Union Health Care Proposals Paul Howard, Ph.D., February 2006
• Reality-driven Health-care Reform Cynthia Ramsay, February 2006
• California’s Uninsured: Not as bad a problem as you might think. John R. Graham, March 2006
• Where Good and Bad Drugs Mix Katherine Eban, March 2006
• Counterfeit drugs: getting to the root of the problem Philip Stevens, March 2006
• Good News on Evista Comes Too Late for Some Gilbert L. Ross, M.D., April 2006
• They'd Sooner Fix Medicaid Regina E. Herzlinger, , Tom Coburn, May 2006
• Where Would You Rather Be Sick? David Gratzer, June 2006
• How Safe and Effective is the FDA? Richard A. Epstein, June 2006
• The Cost of a Caring Leviathan: The FDA at 100 John R. Graham, July 2006
• A Tale of Two Anniversaries David Gratzer, July 2006
• The FDA at 100 Henry I. Miller, July 2006
• The Bureaucratization of Safety and Effectiveness Benjamin Zycher, Ph.D., July 2006
• How Depressed are U.S. Drug Consumers? John Vernon, , Rexford Santerre, September 2006
• Medicine and Conflicts of Interest: Creating A New Morality Michael Weber, M.D., October 2006
• The Hidden Costs of Conflicts of Interest Regulation Richard A. Epstein, October 2006
• FDA Advisory Committees and Conflicts of Interest: Understanding the Coinage of the Realm John Calfee, October 2006
• Getting Off the Latest Beltway Bandwagon: Benjamin Zycher, Ph.D., October 2006
• For Health Care Woes, a Capitalism Prescription David Gratzer, October 2006
• RX for New York's Ailing Health Care David Gratzer, November 2006
• A Tale Of Two Drug Classes Shows Why U.S. Mustn't Go Europe's Way Paul Howard, Ph.D., December 2006
• We oppose negotiations on Medicare Part D drug prices Benjamin Zycher, Ph.D., January 2007
• Where Has Bird Flu Flown? Marc Siegel, MD, February 2007
• Pharmaceutical Importation, Price Controls, Federal Price Negotiations, and the Interests of Consumers
• Who Killed U.S. Medicine? Regina E. Herzlinger, July 2007
• Congress Is Full of SCHIP Paul Howard, Ph.D., July 2007
• CAMBRIDGE V CHICAGO:
  AN ANSWER TO DR. ARNOLD RELMAN’S NEW REPUBLIC REVIEW OF OVERDOSE Richard A. Epstein, August 2007
• Bush right to curb insurance 'crowd out' Tarren Bragdon, September 2007
• An Information Prescription for Drug Regulation Joseph Bernstein, MD, FACS, , Anita Bernstein, JD, August 2007
• HILLARYCARE'S 'GROUNDHOG DAY' Paul Howard, Ph.D., September 2007
• To Save Cancer Patients in the UK, the NHS Needs a Dose of Competition Andrew Haldenby, November 2007
• Rudy Is Right In Data Duel About Cancer David Gratzer, November 2007
• The free lunch never dies Benjamin Zycher, Ph.D., November 2007
• Foreign Health Affairs Regina E. Herzlinger, November 2007
• The Health Of Nations Paul Howard, Ph.D., December 2007
• A Question for Hillary Tarren Bragdon, January 2008
• Free to Choose? Benjamin Zycher, Ph.D., February 2008
• McCain is wrong on drugs David Gratzer, March 2008
• Conflicted doctors Peter Huber, April 2008
• America, Insure Thyself Regina E. Herzlinger, March 2008

• Lynch 'Em Forbes, 6-18-07
• Science is not a democracy by Gilbert L. Ross, M.D., Washington Times, 6-15-07
• Avandia-type crisis could hit other drugs Reuters News, 6-4-07
• Balancing Medical Risks; The FDA needs more authority to monitor drugs following their approval Washington Post, 6-4-07
• At risk: vaccines by Paul A. Offit, The Boston Globe, 6-3-07
• Glaxo Letter Defends Avandia Wall Street Journal, 5-31-07
• The Obama Health Plan by Atul Gawande, The New York Times, 5-31-07
• Evolving Beyond Traditional Employer-Sponsored Health Insurance by Stuart Butler, Brookings Institution, 5-31-07
• Journalistic Malpractice by Dr. Scott Gottlieb, Wall Street Journal, 5-29-07
• We’re seeking more data: FDA protects public health with careful analysis, not snap judgments by Andrew von Eschenbach, USA Today, 5-23-07
• Does a drug firms free lunch influence doctors? by Scott Lassman, The Boston Globe, 5-18-07
• Sometimes, what’s needed is a nudge by David Leonhardt, The New York Times, 5-16-07
• Financial Cure Overdue: America’s ailing Medicare, Social Security Programs The Atlanta Journal–Constitution, 4-26-07
• The Angel is in the Details by Henry I. Miller, TCS Daily, 4-25-07
• Responsible Medicine by Tom Coburn, Washington Times, 4-24-07
• Risky Drug Business by Richard A. Epstein, Wall Street Journal, 4-24-07
• Black Box Backfire by Gilbert L. Ross, M.D., Wall Street Journal, 4-21-07
• Hospitals Check Their Charts: Rankings Push Them to Improve Care by Steven Pearlstein, Washington Post, 4-20-07
• Do politicians know better than patients? by Jon Kyl, Real Clear Politics, 4-18-07
• Bitter Pills Wall Street Journal, 4-18-07
• Drug Danger by Dr. Scott Gottlieb, Wall Street Journal, 4-17-07
• Drugs and Demagogues by Thomas P. Stossel, M.D., The Boston Globe, 4-17-07
• Drug safety reform at the FDA New England Journal of Medicine, 4-13-07
• A year later, healthcare experiment has vital signs by John McDonough, The Boston Globe, 4-11-07
• Boomer Boomerang by Robert J. Samuelson, Washington Post, 4-11-07
• Perverse incentives in health care by John Goodman, Wall Street Journal, 4-5-07
• Shotgun Medicine, Flimsy Evidence by Dr. Eric Topol, Baltimore Sun, 4-3-07
• Restricted Treatment by Robert Goldberg, Ph.D., Washington Times, 3-29-07
• Disruptive Innovation: Can Health Care Learn From Other Industries? A Conversation with Clayton M. Christensen Health Affairs, 3-13-07
• Medicine and Markets by Dr. Scott Gottlieb, Forbes, 3-12-07
• Prescription for Trouble by Dr. Scott Gottlieb, Wall Street Journal, 3-6-07
• Why I'm Fighting – The Health Care New York Needs by Eliot Spitzer, New York Post, 3-5-07
• Medical Nihilism and the HPV Vaccine by Ivan Oransky, The Boston Globe, 3-4-07
• The Fear Industrial Complex by John Stossel, Real Clear Politics, 2-28-07
• If profit is bad, why choose Michigan? by Chuck Moss, Detroit News, 2-28-07
• Overdose of restraints could sicken industry by Michael H. Davidson, Chicago Sun-Times, 2-27-07
• Intensive Care for RomneyCare by Sally C. Pipes, Wall Street Journal, 2-26-07
• What price health? Investor's Business Daily, 2-23-07
• The Rise of In-Store Clinics – Threat or Opportunity New England Journal of Medicine, 2-22-07
• A Dog's Breakfast by Daniel L. McFadden, Wall Street Journal, 2-16-07
• Texas HPV mandate not quite compelling by Steve Chapman, Chicago Tribune, 2-15-07
• Lean New Pharma by Dr. Scott Gottlieb, Forbes, 2-14-07
• Adding up the reason's for expensive health care by Steven Pearlstein, Washington Post, 2-14-07
• The Clinical Trial by Mark Thornton, Wall Street Journal, 2-12-07
• No Perfect Pill: Safe for all shouldn't be FDA standard The San Diego Union-Tribune, 2-10-07
• My order protects life: Vaccine mandate will prevent deaths, give parents the final word USA Today, 2-9-07
• The Truth About the Drug Ads by John Calfee, The American, 2-7-07
• Fact: No link of vaccine, autism by Arthur Caplan, The Philadelphia Inquirer, 2-6-07
• Orthopedists for Vioxx Wall Street Journal, 2-3-07
• Doctoring Medicaid by Tarren Bragdon, New York Sun, 1-25-07
• Health and Taxes Wall Street Journal, 1-24-07
• State plans miss the point USA Today, 1-15-07
• No crisis of the uninsured by Mike Rosen, Rocky Mountain News, 1-12-07
• The Real Dangers of Medicare by John Calfee, New York Sun, 1-12-07
• Medicare and the Market: Government Shouldn’t Be Negotiating Prescription Prices by Mike Leavitt, Washington Post, 1-11-07
• License to Ill by Benjamin Zycher, Ph.D., National Review Online, 1-11-07
• Terminatorcare by David R. Henderson, Wall Street Journal, 1-10-07
• Medicare Part D and Prescription Drug Prices
  Policy Fact Sheet by Mark McClellan, Pacific Research Institute, 1-9-07
• Pharma in Europe: Going from Heartburn to Heart Attack? by Jurgen Reinhoudt, The American, 1-4-07
• Review and Outlook: The 100 Hours Rush Wall Street Journal, 1-4-07
• Don't infect Medicare with Price Controls by Deroy Murdock, Union Leader, 1-1-07
• The myth of the big bad drug companies by Richard A. Epstein, Los Angeles Times, 12-22-06
• We're Not Your Drugstore by Louise Crandall, New York Sun, 12-20-06
• Drug Ads: Kill the Messenger by Sally C. Pipes, New York Post, 12-19-06
• Don't Expose drug makers to business killing lawsuits Detroit News, 12-18-06
• Anti–depressants and labels Eye on FDA, 12-14-06
• Fighting Drug Fakes The New York Times, 12-12-06
• Bad Medicine New York Sun, 12-12-06
• Let's Pay Up for Alzheimer's by Newt Gingrich, by Robert Egge, Business Week, 12-11-06
• Pharmaceutical R& D Washington Times, 12-8-06
• Yes. Let the Government Bargain with Drugmakers by Karen Davenport, The Philadelphia Inquirer, 12-6-06
• No. Private Insurers are Already Getting Discounts by Robert E. Moffit, Ph.D., The Philadelphia Inquirer, 12-6-06
• Little Big Pharma Wall Street Journal, 12-6-06
• Renew Milton Friedman's Conservatism by Newt Gingrich, AEI Online, 12-4-06
• National Health Care? We're Halfway There by Daniel Gross, The New York Times, 12-3-06
• Seniors, Be Careful What You Wish For Seattle Post-Intelligencer, 12-3-06
• What's Good for Pharma is Good for America by Richard A. Epstein, The Boston Globe, 12-3-06
• Employer Sponsored, Personal, and Portable Health Insurance by John Goodman, Health Affairs, 12-1-06
• Taking Cola to Court by Walter K. Olson, City Journal, 12-1-06
• Medicaid on the Mend USA Today, 11-28-06
• Prescription for Healing Health Care by Thomas P. Hartnet, Buffalo News, 11-26-06
• The Market's Medicine Orange County Register, 11-26-06
• Ankle Deep in Medicare Madness The Globe and Mail, 11-23-06
• Drugstore Cowboys The Dallas Morning News, 11-21-06
• Questionable Cure for a Questionable Crisis: The Massachusetts Health Plan Takes Shape by Sally C. Pipes, Pacific Research Institute, 11-20-06
• A Drug Price Path to Avoid by Alberto Mingardi, Washington Post, 11-12-06
• Playing Medi-Scare Again by Newt Gingrich, Washington Times, 11-8-06
• Medicaid Advantage: A Medical Home for Dual-Eligibles by Robert B. Helms, Ph.D., by Grace-Marie Turner, Galen Institute, 11-7-06
• Mass Medical Mess by Sally C. Pipes, Washington Times, 11-5-06
• Rolling the Health Dice by Milt Freudenheim, by Reed Abelson, The New York Times, 11-4-06
• An Election on Drugs Washington Post, 11-2-06
• Paying for Performance by Elliott S. Fisher, New England Journal of Medicine, 11-2-06
• Protecting the Health of the Public—Institute of Medicine Recommendations of Drug Safety by Sheila Burke, by Bruce M. Psaty, Ph.D., New England Journal of Medicine, 10-26-06
• Building on the Successes of Health Savings Accounts by Robert E. Moffit, Ph.D., by Greg D'Angelo, Heritage Foundation, 10-20-06
• Competition Good For Your Health (Care) by Robert E. Moffit, Ph.D., Washington Times, 10-19-06
• The Medicare Drug Benefit: What Happened? by Karlyn Bowman, American Enterprise Institute, 10-19-06
• A Lesson From Europe On Health Care by David Leonhardt, The New York Times, 10-18-06
• The Dangers of Undermining Patient Choice: Lessons from Europe and Canada Institute for Policy Innovation, Galen Institute, International Policy Network, 10-18-06
• Anthrax and Lawyers by Peter Huber, Forbes, 10-16-06
• Faster FDA Cures Wall Street Journal, 10-13-06
• Fix Medicare, Not Its Prices by Michael Cannon, Cato Institute, 10-10-06
• Are Bad Drugs Coming to a Pharmacy Near You? by Henry I. Miller, Tech Central Station, 10-4-06
• Markets and Medicare Wall Street Journal, 10-4-06
• Markets and Medicare Wall Street Journal, 10-4-06
• Common Sense on Medicare Chicago Tribune, 9-25-06
• Medical Mindset by Sally C. Pipes, National Review Online, 9-21-06
• Apples and Oranges by Grace-Marie Turner, Galen Institute, 9-15-06
• Medical Tourism: Why Americans Take Medical Vacations Abroad by Diana M. Ernst, Pacific Research Institute, 9-15-06
• Medicare: The Monster at Our Door by Robert J. Samuelson, Real Clear Politics, 9-13-06
• I Cannot Support Socialized Medicine by Arnold Schwarzenegger, The San Diego Union-Tribune, 9-5-06
• Bad Medicine by Robert Goldberg, Ph.D., National Review Online, 8-28-06
• California's Real Drug Problem Investor's Business Daily, 8-24-06
• Counterfeit Drugs: Coming to a Pharmacy Near You by Wyatt Yankus, ACSH, 8-24-06
• Arnold's Raw Deal by Sally C. Pipes, Opinion Journal, 8-16-06
• Filing the Doughnut Hole by Grace-Marie Turner, Galen Institute, 8-14-06
• Curing European Health Care by Helen Disney, Wall Street Journal, 8-9-06
• Justice Scams by Ted Frank, AEI Online, 8-8-06
• Access Before Approval – A Right to Take Experimental Drugs? by Susan Okie, M.D., New England Journal of Medicine, 8-3-06
• Health Care Costs Threaten Nation’s Economic Dominance by Newt Gingrich, by Michael I. Mackness, by David Merritt, Chicago Sun-Times, 7-31-06
• Getting Moving on Health Care by John F. Kerry, The Boston Globe, 7-31-06
• Asking for a Crisis Investor's Business Daily, 7-31-06
• The Massachusetts Health Plan: Lessons for the States by Robert E. Moffit, Ph.D., by Nina Owcharenko, Heritage Backgrounder, 7-18-06
• The Health Care Choice Act: Eliminating Barriers to Personal Freedom and Market Competition by Robert E. Moffit, Ph.D., Heritage Foundation, 7-17-06
• Competition Works by Grace-Marie Turner, Galen Institute, 7-14-06
• Drug Prescription Plan Works For Seniors by Candace Miller, Detroit News, 7-12-06
• Who's In Charge? by Marc Siegel, MD, Washington Post, 7-11-06
• Bismark's Health Plan Wall Street Journal, 7-7-06
• Grading Surgeons May Be A Healthy Practice by David Wessel, Wall Street Journal, 7-6-06
• A Sucker Is Born St. Louis Post-Dispatch, 7-3-06
• What's Wrong with Money In Science? by Thomas P. Stossel, M.D., by David Shaywitz, Washington Post, 7-2-06
• Of Pills and Profits: In Defense of Big Pharma by Peter Huber, Commentary, 7-1-06
• Antidepressants and the Numbing–Down of America by Sally Satel, MD, AEI Online, 6-30-06
• Restraining Doctors Isn't the Answer by Stephen Hoffman, The Boston Globe, 6-29-06
• Streamlining Drug Approval by Peter J. Pitts, by Robert Goldberg, Ph.D., by Robert Peter Gale, Washington Times, 6-22-06
• Forget Vioxx? by Matthew Herper, Forbes, 6-21-06
• Medicare Mess Guaranteed to Grow by Robert E. Moffit, Ph.D., Washington Times, 6-14-06
• A Vaccination Against Complacency by Wendy Everett, The Boston Globe, 6-13-06
• Now Bring Vioxx Back Wall Street Journal, 6-8-06
• More aid will not prevent more AIDS by Philip Stevens, Bangkok Post, 6-5-06
• The Drug Benefit: A Report Card The New York Times, 6-5-06
• Drug delusions at the WHO by Andres Mejia-Vergnaud, International Policy Network, 5-23-06
• Government-Controlled Pharmaceutical Research and Development: A Recipe for Disaster by Richard Tren, by Roger Bate, AEI Online, 5-22-06
• Price Gouging is Bad Medicine by Alexander Tabarrok, Wall Street Journal, 5-20-06
• How safe is too safe? by Matthew W. Strobeck, by Tomas Philipson, by Adrian H. B. Gottschalk, by Ernst R. Berndt, Milken Institute Review, 5-19-06
• They'd Sooner Fix Medicaid by Tom Coburn, by Regina E. Herzlinger, Manhattan Institute, 5-18-06
• Evidence Based Health Policy Against Fads by Anders Sandberg, Center for the New Europe, 5-18-06
• Death's Waiting List by Sally Satel, MD, The New York Times, 5-15-06
• Try and Try Again by Grace-Marie Turner, Galen Institute, 5-12-06
• Get the Facts: Attacks on President Bush's drug plan could be costing seniors dearly Orlando Sentinel, 5-10-06
• Congress Drops the Ball on Medical Liability Reform by Bill Frist, The Seattle Times, 5-10-06
• Health Insurance Showdown Wall Street Journal, 5-9-06
• Prodigal State by Newt Gingrich, Wall Street Journal, 5-4-06
• Bad Bugs, Few Drugs by Henry I. Miller, Washington Times, 5-3-06
• Risky Business by Carl J. Schramm, Wall Street Journal Europe, 5-3-06
• Crisis du Jour or the Real Thing? by Joe Antos, American Enterprise Institute, 5-3-06
• Patient Power: The FDA Doesn’t Have to Decide Everything by John Calfee, The Weekly Standard, 5-1-06
• Competition is the Way by John Shadegg, by Jim DeMint, Washington Times, 5-1-06
• Medical Liability Repair by Stuart Weinstein, Washington Times, 4-30-06
• A Serious Senate Agenda for "Health Week" by Nina Owcharenko, by Robert E. Moffit, Ph.D., Heritage Foundation, 4-30-06
• Three simple solutions to cure Medicare prescription-plan ills by Richard G. Stefanacci, The Philadelphia Inquirer, 4-16-06
• Health Policy in Maryland and Massachusetts: A Study in Contrasts by Regina E. Herzlinger, Heritage Foundation, 4-13-06
• Rein in the Monster by John Calfee, New York Sun, 4-12-06
• Power to the Patients by Peter J. Pitts, Wall Street Journal Europe, 4-12-06
• Health Care for Everyone? We’ve Found a Way by Mitt Romney, Wall Street Journal, 4-11-06
• Massachusetts will fail by Sally C. Pipes, USA Today, 4-9-06
• The FDA and MS Wall Street Journal, 4-7-06
• Bill of Health by Arnold Kling, Wall Street Journal, 4-6-06
• Health Savings Accounts: It’s All Good by Grace-Marie Turner, Galen Institute, 4-6-06
• Favorable Medicare Access Washington Times, 4-4-06
• The Health of a Nation by Alan Hubbard, The New York Times, 4-3-06
• The Vaccine Crisis by Marilyn Webber, National Journal, 4-1-06
• Drug Makers First Target of Trial Lawyers by Stephen Hantler, Michigan Forward, 4-1-06
• Medicare? But that’s for old people by Michael Cannon, Washington Times, 4-1-06
• A Healthy Medicare Drug Plan by David Merritt, by Newt Gingrich, The Boston Globe, 3-30-06
• A Foolish Way to Fight Fraud by Steve Malanga, New York Post, 3-29-06
• Governments Restrict Access to Healthcare and Prevent Medicine Development: International Policy Network, 3-28-06
• Playing Catch-Up: The FDA, Science, and Drug Regulation by Joseph Calfee, Ph.D., American Enterprise Institute, 3-28-06
• Health-care reform: Be patient by Alex Gerber, Washington Times, 3-26-06
• Health Advisors by Grace-Marie Turner, Galen Institute, 3-24-06
• The Real Cost of AIDS in Sierra Leone by Roger Bate, Economic Affairs, 3-21-06
• Florida Empowers Health-Care Consumers by David Merritt, by Newt Gingrich, Tallahassee Democrat, 3-16-06
• Save the Medicare Benefit Washington Times, 3-15-06
• When Fear Is Deadly by Phillip K. Howard, New York Sun, 3-14-06
• Speech at Commonwealth Club by Mike Leavitt, Secretary of Health and Human Services, 3-14-06
• Sticker shock could help with healthcare costs by Newt Gingrich, by James Frogue, The Hill, 3-8-06
• The hip that changed health care history by David Gratzer, National Post, 3-7-06
• Drug Reckoning Wall Street Journal, 3-6-06
• Shop and Compare Hospital Care by Bob Moos, The Dallas Morning News, 3-5-06
• Letter to the Editor: Juryless Health Courts Could Stabilize 'Crisis' by Phillip K. Howard, Wall Street Journal, 2-28-06
• Price Transparency by Grace-Marie Turner, Galen Institute, 2-24-06
• Cancer Prognosis Wall Street Journal, 2-23-06
• Biased Doctors? by Sally Satel, MD, National Review Online, 2-23-06
• Consumers’ Role in Health Care by Jim DeMint, The State.com, 2-22-06
• Demon drugs; Industry faces chorus of critics The Oklahoman, 2-21-06
• Health savings accounts look like brain wave of the future by Michael Barone, Chicago Sun-Times, 2-21-06
• Patient Power Investor's Business Daily, 2-17-06
• Doctors, Post Your Prices by Scott W. Atlas, MD, Wall Street Journal, 2-17-06
• Pharma Pain: Canada Must Revamp its Drug Pricing Policies or Face Shortages as U.S. Demand Siphons Off Our Supply by Brett J. Skinner, National Post, 2-16-06
• Thwart Hillarycare 2006 by Robert Goldberg, Ph.D., Washington Times, 2-2-06
• What Did Those Asbestos X-Rays Really Show? by Lester Brickman, PointofLaw.com, 2-2-06
• The Health Care Opportunity Wall Street Journal, 2-1-06
• Do the math; you'll like health savings by Grace-Marie Turner, The Atlanta Journal–Constitution, 1-31-06
• The Health of the Union by George Melloan, Wall Street Journal, 1-31-06
• Under an Avalanche by Grace-Marie Turner, Galen Institute, 1-26-06
• Health Coverage Chaos by Deroy Murdock, Washington Times, 1-23-06
• Californians Should Reject Drug Importation by Tommy G. Thompson, The San Diego Union-Tribune, 1-19-06
• New England Journal of Politics Wall Street Journal, 1-16-06
• HilaryCare Returns Wall Street Journal, 1-16-06
• Keep Government Out by Daniel P. Kessler, by R. Glenn Hubbard, by John F. Cogan, AEI Online, 1-13-06
• Revolutionizing health care by Robert Goldberg, Ph.D., Manhattan Institute, 1-11-06
• California's Uninsured: Crisis, Conundrum, or Chronic Condition? by John R. Graham, Pacific Research Institute, 1-10-06
• High on the drug benefit by Grace-Marie Turner, Galen Institute, 1-6-06
• A healthy strategy Los Angeles Times, 1-4-06
• Cutting through the confusion in Part D by Joseph R. Antos, Ph.D., AEI Online, 1-4-06
• Ominous Prospects for an Aging Population Tech Central Station, 1-3-06
• Vexing Vioxx Washington Post, 1-2-06
• Prescription for trouble Consumer Reports, 1-1-06
• Mere Magazines by Thomas P. Stossel, M.D., Wall Street Journal, 12-30-05
• Lessons from Vioxx The Boston Globe, 12-19-05
• Vaccine Liability: Congress Should Give Vaccines a Shot in the Arm by Randolph W. Pate, J.D., MPH, Heritage Foundation, 12-16-05
• The Grassley Drug Plan by Robert Goldberg, Ph.D., Washington Times, 12-15-05
• New Medicaid Model by Jeb Bush, Washington Times, 12-15-05
• Gouging The Drug Companies by Peter Huber, Forbes, 12-12-05
• Expression of Concern: Bombardier et al., “Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis” by Gregory Curfman, New England Journal of Medicine, 12-8-05
• Making Sense of Drug Safety by Henry Miller, M.S., M.D., Washington Times, 12-7-05
• Don’t Monkey With Seniors Medicare Savings by Grace-Marie Turner, Galen Institute, 12-7-05
• Growing and Collapsing by Grace-Marie Turner, National Review Online, 12-6-05
• WHO’s in Charge? by Philip Stevens, National Review Online, 12-2-05
• Lawsuits Won’t Stop Pandemics by Paul A. Offit, Wall Street Journal, 12-1-05
• Confusing Choices in Medicare? by Grace-Marie Turner, Galen Institute, 11-28-05
• The "Choo-Choo Man" Party on the Outs by David Gratzer, National Review Online, 11-28-05
• AARP’s America is a Mirage by Robert J. Samuelson, Washington Post, 11-16-05
• The Senate Reconciliation Bill: Wrapping Doctors in More Medicare Red Tape by Richard Dolinar, M.D., Heritage Foundation, 11-10-05
• Flu shot priorities by Gilbert L. Ross, M.D., Washington Times, 11-9-05
• Health Care Tax Credits: Designing an Alternative to Employer-Based Coverage by Nina Owcharenko, Heritage Foundation, 11-9-05
• Public Health Care on Path to Bankruptcy by Brett J. Skinner, The Fraser Institute, 11-8-05
• Pandemics and Lawsuits by Robert Goldberg, Ph.D., Washington Times, 11-7-05
• Under fire, a giant employer offers a useful health plan USA Today, 11-7-05
• Halloween Part II: Dawn of Price Controls: Each year, Congress resurrects a bad policy by Robert Goldberg, Ph.D., Medical News Today, 11-3-05
• Prescription Drug Payola by Merrill Matthews, Ph.D., Center for Medical Progress, 11-3-05
• Early comments on Humeston defense verdict by Ted Frank, PointofLaw.com, 11-3-05
• Guaranteed Future Pain and Suffering: The Recent Research on Drug Price Controls by Derek Hunter, Heritage Foundation, 11-3-05
• Patent Nonsense on avian flu by Alec van Gelder, The Boston Globe, 10-31-05
• In Control of My Health by David Gratzer, New York Sun, 10-28-05
• A Comparison of Propositions 78 and 79, Prescription Drug Pricing Initiatives in the November 8, 2005, Special Election by John R. Graham, Pacific Research Institute, 10-27-05
• Baby Steps: Congressional Action on Medicaid Reform by Nina Owcharenko, Heritage Foundation, 10-27-05
• The Effect of State Regulations on Health Insurance Premiums: A Preliminary Analysis by Michael New, Heritage Foundation, 10-27-05
• May Reagan GOP R.I.P by Robert Goldberg, Ph.D., Washington Times, 10-26-05
• Values-Driven Healthcare: Freedom of Conscience for the Consumer by Robert E. Moffit, Ph.D., Heritage Foundation, 10-25-05
• Healthy profits have healing powers by Benjamin Zycher, Ph.D., Los Angeles Times, 10-25-05
• U.S. Consumers Shafted by European Price Controls by James K. Glassman, Scripps Howard News Service, 10-25-05
• Florida's Medicaid Gamble The New York Times, 10-24-05
• Hot Topic: Political Virus Wall Street Journal, 10-22-05
• Drugs companies are not on the same level as arms dealers by Andrew Jack, Financial Times, 10-15-05
• Idealistic, It’s Not: Consumers Union wrong to tout Prop. The San Diego Union-Tribune, 10-14-05
• Paying for Medicare: An Economic Look at the Program's Unfunded Liabilities by Tracy L. Foertsch, Ph.D., by Joseph R. Antos, Ph.D., Heritage Foundation, 10-11-05
• High stakes in the Hague by Johan Hjertqvist, Center for the New Europe, 10-10-05
• Counterfeit Pharmaceuticals and the Public Health by Ronald W. Buzzeo, Wall Street Journal, 10-4-05
• Medicaid’s Code Red by Louis S. Richman, The New York Times, 10-2-05
• In praise of U.S. health care by Michael Tanner, Washington Times, 10-1-05
• Good News All Around by Grace-Marie Turner, Galen Institute, 10-1-05
• The New Pill Isn't Always the Best Pill by Sally Satel, MD, National Review Online, 9-28-05
• Regime Change at the FDA Wall Street Journal, 9-27-05
• Compulsory social responsibility by Martin Krause, Washington Times, 9-27-05
• Katrina's Victims Deserve Better than Medicaid by Nina Owcharenko, Heritage Foundation, 9-26-05
• The White House Is Right To Threaten a Veto on Drug Importation by Andrew Grossman, Heritage Foundation, 9-21-05
• Medicaid is behind the decline in private health coverage by Michael Cannon, New Hampshire Union Leader, 9-19-05
• Health Care and Homeland Security: It’s Catastrophic to Have One without the Other by David Merritt, by Newt Gingrich, Chicago Tribune, 9-19-05
• The Companies Everyone Loves to Hate by Roger Bate, Wall Street Journal, 9-16-05
• The Vioxx Hex Washington Post, 9-16-05
• Command and Control: Maine’s Dirigo Health Care Program by Tarren Bragdon, Heritage Foundation, 9-15-05
• Health Savings Accounts: The News Keeps Getting Better by Derek Hunter, Heritage Foundation, 9-6-05
• Vioxx-type danger and legal frivolity by Robert Goldberg, Ph.D., Washington Times, 8-24-05
• A dangerous Vioxx verdict Chicago Tribune, 8-24-05
• Vioxx verdict’s dark side by A. Mitchell Polinsky, by Steven Shavell, The Boston Globe, 8-23-05
• Son of Sanford Wall Street Journal, 8-23-05
• Suggested side-effects - The Vioxx verdict should serve to stimulate tort reform. Financial Times, 8-23-05
• Vioxx Verdict Wall Street Journal, 8-22-05
• Ambush In Angleton by Richard A. Epstein, Wall Street Journal, 8-22-05
• The doctors' chance to lead by Edwin Coffey, by Victor Dirnfeld, by David Gratzer, National Post, 8-16-05
• Prevention is still key to fighting AIDS plague by Franklin Cudjoe, Campaign for Fighting Diseases, 8-14-05
• Canada's 'Free' Health Care Has a High Price Tag by John Fund, Wall Street Journal, 8-12-05
• Let People Choose by David Gratzer, New York Sun, 8-11-05
• Consumerism in Health Care: Early Evidence is Positive by Grace-Marie Turner, Galen Institute, 8-11-05
• OUR VIEWS: 'Paradise' pills The Press-Enterprise, 8-7-05
• OUR OPINIONS: Not buying this 'remedy' Not enough that the pharmaceutical industry plans to reduce consumer ads. FDA controls are needed, too The Atlanta Journal–Constitution, 8-5-05
• California Dreamin' by Grace-Marie Turner, Galen Institute, 8-5-05
• Health Monopoly Makes Canada Odd Nation Out by Nadeem Esmail, The Fraser Institute, 8-4-05
• Medicare: Yesterday and Tomorrow by Joseph R. Antos, Ph.D., American Enterprise Institute, 8-2-05
• Medicine for Medicaid by Tom Nerney, by Regina E. Herzlinger, Wall Street Journal, 8-2-05
• Cheaper Health Insurance Wall Street Journal, 7-25-05
• Don't fear the vaccines The Globe and Mail, 7-25-05
• Hitting targets, missing dignity by Dr. Eamonn Butler, Adam Smith Institute, 7-24-05
• Why we must invest in electronic medical records by Bill Frist, The San Francisco Chronicle, 7-24-05
• Profits and the development of drugs by Linda Gorman, Denver Post, 7-24-05
• Who's Minding Medicaid? The New York Times, 7-20-05
• Editorials/Op-ED: Vaccines and autism Washington Times, 7-15-05
• Small Leaps or Giant Steps by Dr. Scott Gottlieb, AEI Online, 7-13-05
• A Drug-Ad Ban Is Tough To Swallow by Charles Stein, The Boston Globe, 7-10-05
• Reimportation Threatens Innovation by Orrin Hatch, Roll Call, 7-7-05
• Congress Got Something Right by David Gratzer, Wall Street Journal, 7-5-05
• The Future of healthcare in Africa British Medical Journal, 7-2-05
• Opening Pandora's Pillbox by Dr. Scott Gottlieb, Health Affairs, 7-1-05
• Medicaid's Untallied Costs by Michael Cannon, Cato Institute, 7-1-05
• Power to the African People by Julian Morris, The Spectator, 6-29-05
• An end to the party line by David Gratzer, Macleans.ca, 6-14-05
• Accelerate drug approval by Robert Goldberg, Ph.D., Washington Times, 6-14-05
• A Better Prescription by Bruce Mehlman, Washington Times, 6-10-05
• The Wall Tumbles by Grace-Marie Turner, Galen Institute, 6-9-05
• FDA Disappoints Lung Transplant Patients by Dr. Scott Gottlieb, Forbes, 6-8-05
• Unequal care troubles CEO by Tom Walsh, Detroit Free Press, 6-7-05
• The WHO: A Time for Reconstitution by Richard E. Wagner, Campaign for Fighting Diseases, 6-1-05
• TAMING MEDICAID Taming NY's Medicaid beast NY taxpayers spend twice as much on Medicaid than those in the next closest state Newsday, 5-28-05
• Ensuring That All Are Equally Ill Investor's Business Daily, 5-25-05
• Health Savings Accounts for Seniors Washington Times, 5-21-05
• The FDA vs. Cancer Patients Wall Street Journal, 5-19-05
• A New Prescription for Health Care by David Gratzer, National Review Online, 5-16-05
• Innovators by Grace-Marie Turner, Galen Institute, 5-13-05
• FDA goes straight to press by Dr. Scott Gottlieb, USA Today, 5-11-05
• Health Care Won't Solve Auto Woes by Tom Bray, New York Sun, 5-11-05
• Commentary: Prescription for Disaster; The District's proposal to regulate the price of drugs would hinder scientific progress. Washington Post, 5-8-05
• A Pharmaceutical Free Lunch? by Doug Bandow, Townhall.com, 5-2-05
• How to Fix Health Care by Dan Crippen, Washington Post, 5-1-05
• Health Bulletin Center for the New Europe, 5-1-05
• Why Are Pharmaceutical Companies Gradually Abandoning Vaccines? by Paul A. Offit, Health Affairs, 5-1-05
• To spare the pain by Elizabeth Whelan, Washington Times, 4-31-05
• Is the FDA Broken? by Joseph Calfee, Ph.D., Tech Central Station, 4-30-05
• A Private Obsession by Paul Krugman, The New York Times, 4-29-05
• The 'European disease' by Robert Goldberg, Ph.D., Washington Times, 4-28-05
• A Lethal Guardian: The Canadian Government's Ban on Prescription Drugs by John R. Graham, The Fraser Institute, 4-28-05
• FDA policy reforms sorely needed to improve safety by Henry Miller, M.S., M.D., Detroit Free Press, 4-28-05
• FDA in a pain-pill panic Washington Times, 4-26-05
• Cracks in High Drug Prices; Change is in the air as Congress looks at legalizing orders from foreign companies. Los Angeles Times, 4-22-05
• Taxed to Death by Jasson Urbach, by Richard Tren, by Roger Bate, AEI-Brookings Joint Center for Regulatory Studies, 4-21-05
• Don’t get old by Tony Blankely, Washington Times, 4-20-05
• WHAT'S NEEDED ON PRESCRIPTION LABELS by Steven Wolosin, by Lisa M. Schwartz, The Boston Globe, 4-20-05
• The Drug Approval Pendulum by Anne Applebaum, Washington Post, 4-19-05
• Bargain fares on Rx express? by Elizabeth Whelan, Washington Times, 4-18-05
• Letters to the Editor: Dying While Waiting for the FDA to Act Wall Street Journal, 4-15-05
• Medical R&D Miracle by Doug Bandow, Washington Times, 4-12-05
• The Top Ten Reasons for Medicaid Reform by Nina Owcharenko, Heritage Foundation, 4-12-05
• Data Do Not Support Ban on Silicone Breast Implants by Sally Satel, MD, USA Today, 4-11-05
• The Secret Truth: Parents Used to Accept Routine Vaccinations For Their Children Without a Second Thought. by Darshak Sanghavi, The Boston Globe, 4-5-05
• Banks: The New HMOs by Dr. Scott Gottlieb, Forbes, 4-4-05
• What ails health care by David Gratzer, The Public Interest, 4-1-05
• Kianna's Legacy Wall Street Journal, 3-29-05
• A Malaria Success The New York Times, 3-27-05
• A BALANCED LOOK AT COX-2 DRUGS by Timothy Hla, The Boston Globe, 3-25-05
• REVIEW & OUTLOOK (Editorial): How About a 'Kianna's Law'? Wall Street Journal, 3-24-05
• Putting Profits ahead of Patients by Dr. Scott Gottlieb, Forbes, 3-17-05
• A Troubling Drug Combination The New York Times, 3-15-05
• Rules Are Killing Good Science by Henry Miller, M.S., M.D., Los Angeles Times, 3-14-05
• The Quality Cure? The New York Times, 3-13-05
• RX FOR MEDICARE by Lois Quam, The Boston Globe, 3-11-05
• Health Policy on a Budget by Joseph R. Antos, Ph.D., Health Policy Outlook, American Enterprise Institute, 3-10-05
• The costs of health care by Doug Bandow, Washington Times, 3-2-05
• Drug Twilight Zone Wall Street Journal, 3-2-05
• Conflict on drug reviews The Star-Ledger, 2-28-05
• BACK TO SANITY ON COX-2 DRUGS ; PATIENTS, DOCTORS CAN WEIGH RISK, REWARDS Rocky Mountain News, 2-28-05
• Reducing Barriers to the Development of High Quality, Low Cost Medicines: A proposal for Reforming the Drug Approval Process International Policy Network, 2-28-05
• Editorial: Too Strict at NIH Washington Post, 2-23-05
• Commentary: A safer Vioxx? Try this remedy by Joe Torg, The Philadelphia Inquirer, 2-23-05
• Commentary: Good Drug, Bad Customers - II by Holman W. Jenkins Jr., Wall Street Journal, 2-23-05
• Viable Vioxx Wall Street Journal, 2-22-05
• F.D.A. Moves Toward More Openness With the Public by Gardner Harris, The New York Times, 2-20-05
• Medicating the FDA by Henry Miller, M.S., M.D., Washington Times, 2-17-05
• Free the Scientists! Conflict-of-interest rules purport to cure a problem that doesn't exist - and are stifling medical progress. Forbes, 2-14-05
• Medicaid needs Surgery by David Gratzer, The Weekly Standard, 2-14-05
• Brouhaha by Grace-Marie Turner, Galen Institute, 2-11-05
• Science Needs A Profit Motive by Steven Pearlstein, Washington Post, 2-4-05
• Medical Bankruptcy Galen Institute, 2-4-05
• Pharma Furor by Richard A. Epstein, Legal Affairs, 2-1-05
• Health of the Union by David Gratzer, Wall Street Journal, 1-26-05
• The Gates Vaccinations Washington Post, 1-25-05
• HSAs Are A-OK by Andy Laperriere, Wall Street Journal, 1-24-05
• The Budget Health Shock by Sebastian Mallaby, Washington Post, 1-24-05
• The burden of staying alive; It's the drugs you can't get that might kill you by Dr. Scott Gottlieb, Chicago Tribune, 1-21-05
• Call 'Negotiated' Drug Prices What They Really Are: Price Controls by Benjamin Zycher, Ph.D., Los Angeles Times, 1-21-05
• Some Gene Research Just Isn't Worth the Money by Keith Humphreys, by Sally Satel, MD, The New York Times, 1-18-05
• FDA Moves Cancer Cures into the Slow Lane by Dr. Scott Gottlieb, Forbes, 1-18-05
• A Gift for Drug Makers by Bob Herbert, The New York Times, 1-14-05
• Editorial: Drug Trade Washington Post, 1-13-05
• The New Heart Disease Threat The New York Times, 1-11-05
• An Overdose of Ads The Boston Globe, 1-6-05
• The Life and Times of Ivermectin - A Success Story by Andy Crump, by Satoshi Õmura, Nature, 1-4-05
• Drug import plan sags USA Today, 1-3-05
• Painkiller panic by Alan Reynolds, Washington Times, 1-2-05
• Medicaid Rx Wall Street Journal, 1-2-05
• How Technocrats are Taking Over the Practice of Medicine: A Wake-Up Call to the American People by Twila Brase, Citizens Council on Health Care, 1-1-05
• Do Not Operate Heavy Equipment While Reading This by Holman W. Jenkins Jr., Wall Street Journal, 12-29-04
• The Right Road To Safe Drugs by Robert Goldberg, Ph.D., New York Post, 12-28-04
• Prescription for Confusion The New York Times, 12-28-04
• A World Of Hurt by William Safire, The New York Times, 12-27-04
• Demonizing the drug business by Deroy Murdock, Washington Times, 12-27-04
• Don’t Blame Canada by Robert Goldberg, Ph.D., National Review Online, 12-23-04
• The Painkiller Panic Wall Street Journal, 12-23-04
• Attacks on Vioxx don't ad up by Paul Mulshine, The Star-Ledger, 12-23-04
• The Price of Too Much Caution by Dr. Scott Gottlieb, New York Sun, 12-22-04
• A Prescription for Health by David Gratzer, National Review Online, 12-21-04
• REVIEW & OUTLOOK (Editorial) Pazdur's Revenge Wall Street Journal, 12-20-04
• Pharmaceutical Group Chiefs March to Individual Beats by Greg Critser, Los Angeles Times, 12-20-04
• Punishing drugmakers for doing good by Doug Bandow, The San Diego Union-Tribune, 12-16-04
• U.S. Health Care Needs a Spark by Newt Gingrich, The Philadelphia Inquirer, 12-15-04
• Fixing Medicare by Laurence J. Kotlikoff, Forbes, 12-13-04
• The High Cost of Cheap Drugs by Jacob Arfwedson, Wall Street Journal Europe, 12-13-04
• The Bell Curve by Atul Gawande, The New Yorker, 12-11-04
• No Silver Bullet by Grace-Marie Turner, Galen Institute, 12-10-04
• Capital: Time to Cure the Health-Choice Headache by David Wessel, Wall Street Journal, 12-9-04
• Minnesota's Health Care Gamble by David Broder, Washington Post, 12-9-04
• Medical progress; Health breakthroughs worth the price by Robert Goldberg, Ph.D., Washington Times, 12-7-04
• HillaryCare in Tennessee Wall Street Journal, 12-6-04
• Letters to the Editor: Patient Data Could Lead to Scientific Insights by Dr. Scott Gottlieb, Wall Street Journal, 12-3-04
• How to Improve Drug Safety by William B. Schultz, Washington Post, 12-2-04
• In praise of Big Pharma's me-too drugs. by John Gapper, Financial Times, 12-2-04
• Commentary: A Culture Of Subsidies Inflates Costs by Steven Pearlstein, Washington Post, 12-1-04
• EDITORIAL: Healing the FDA from within The Star-Ledger, 11-30-04
• Editorial: Looking for Adverse Drug Effects The New York Times, 11-27-04
• Commentary: The Curse of Too Much Caution by Henry Miller, M.S., M.D., Wall Street Journal, 11-26-04
• A prescription for sanity by Mortimer B. Zuckerman, U.S. News & World Report, 11-22-04
• Commentary: Why new drugs cost so much by Deroy Murdock, Washington Times, 11-22-04
• REVIEW & OUTLOOK (Editorial): The Trials of Merck Wall Street Journal, 11-18-04
• On the Contrary: Open Season on Others' Ideas by Daniel Akst, The New York Times, 11-14-04
• BOOKS: Why Canada isn't the answer to health care by Elizabeth Whelan, Washington Times, 11-14-04
• Commentary: Health Care: Beyond Markets Washington Post, 11-11-04
• Commentary: Was Withdrawing Vioxx the 'Right Thing to Do'? by Holman W. Jenkins Jr., Wall Street Journal, 11-10-04
• Welcome to our discussion on medical malpractice by James R. Copland, PointofLaw.com, 11-10-04
• Commentary: Shortages beyond flu shots by Jennifer Brower, Washington Times, 11-9-04
• Editorial: Medicine Tests Washington Post, 11-8-04
• What Federal Workers Are Doing Today that You Can't by Robert E. Moffit, Ph.D., Heritage Foundation, 11-8-04
• EDITORIAL: The answer isn't in Canada The Star-Ledger, 11-2-04
• Letter to the Editor: Europe’s Drug Import Example by Panos Kavanos, Washington Post, 10-30-04
• Commentary: A Booster Shot For Vaccines: New technology could speed development and keep the medicine chest stocked by John Carey, Business Week, 10-25-04
• Vaccine vacuity by Tom Bray, Washington Times, 10-25-04
• High Prices by Malcolm Gladwell, The New Yorker, 10-25-04
• What Ails John Kerry’s Drug Plan? The Globe and Mail, 10-24-04
• Editorial: Flu Wars Washington Post, 10-23-04
• Kerry's toxic drug plan by Robert Goldberg, Ph.D., Washington Times, 10-22-04
• Kerry Win: Bad Medicine For Health Care by Dr. Scott Gottlieb, Forbes, 10-22-04
• How to Get Vaccines, Not Just Viagra Los Angeles Times, 10-19-04
• Kerrycare: This Plan Is Bad for Our Health The Philadelphia Inquirer, 10-17-04
• Imports Can’t Cure Drug Prices Detroit Free Press, 10-15-04
• Booming Internet Drug Sales to Americans are a Prescription for Disaster in Canada The Globe and Mail, 10-14-04
• Infectious Politics Wall Street Journal, 10-14-04
• HSA Man v. Healthzilla Wall Street Journal, 10-12-04
• Big-Biz Bailout New York Post, 10-12-04
• Big Pharma? Think Again Wall Street Journal, 10-12-04
• A Hit Job on the Drug Companies The Standard Reader, 10-11-04
• The Reimportation Blues Wall Street Journal, 10-11-04
• Vaccine Development Needs a Booster Shot Washington Times, 10-10-04
• "Hollywood" Extortion by Robert Goldberg, Ph.D., Washington Times, 10-5-04
• Beware of Doing More Harm by Ruth Rosenberg, Washington Post, 10-3-04
• Money is the Catalyst for Good Medicine by Charles Stein, The Boston Globe, 10-3-04
• Good Riddance to a Bad Drug by Dr. Eric Topol, The New York Times, 10-2-04
• A Vioxx Elegy Wall Street Journal, 10-1-04
• The Free-Market Cure : Republicans, not John Kerry, could provide the right medicine for our health-care system. by David Gratzer, National Review Online, 9-28-04
• The Nation: Venture Medicine: Health Care Costs Are a Killer, but Maybe That's a Plus by Steve Lohr, The New York Times, 9-26-04
• Drug companies under attack by Elizabeth Whelan, Washington Times, 9-21-04
• Health Savings Accounts and the FEHBP: Perfect Together by Andrew Grossman, by Robert E. Moffit, Ph.D., Heritage Foundation, 9-21-04
• ECONOMIC VIEWPOINT A Prescription For Health-Care Reform by R. Glenn Hubbard, Business Week, 9-20-04
• An IT Trojan horse ... Feds should stay out of ‘evidence-based’ medicine by Regina E. Herzlinger, Modern Healthcare, 9-14-04
• Lessons of Success: What Congress Can Learn from the Federal Employees Program by Robert E. Moffit, Ph.D., Heritage Foundation, 9-14-04
• EDITORIAL: The drug makers' problem The Star-Ledger, 9-13-04
• Bad Medicine? The data on anti-depressants and child suicide aren’t conclusive. by Sally Satel, MD, National Review Online, 9-12-04
• Power to the patient by Scott W. Atlas, MD, Washington Times, 9-8-04
• Clinton Got Quick Care, Unlike Canadian Heart Patients by Michael Cannon, Cato Daily Commentary, 9-8-04
• Consumer Driven Healthcare: Lessons from Switzerland by Regina E. Herzlinger, The Journal of the American Medical Association, 9-8-04
• What Health Insurance Crisis? by David Gratzer, Los Angeles Times, 8-29-04
• America's Failing Health by Paul Krugman, The New York Times, 8-27-04
• Commentary: How to Heal Health Care by Hillary Clinton, by Bill Frist, Washington Post, 8-25-04
• Commentary: In search of the next old thing - The copycat culture of America's drug industry by Marcia Angell, The Star-Ledger, 8-22-04
• Editorial: Cover These Treatments by Frank R. Lichtenberg, Washington Post, 8-20-04
• There's a Cure for Frivolous Drug Lawsuits by Henry Miller, M.S., M.D., Los Angeles Times, 8-16-04
• Time for a Drug Test Registry by Marcia Angell, Washington Post, 8-13-04
• Mid-year at the FDA highlights permanent problem by Ken Howard, Nature, 8-9-04
• Lower Cholesterol Without Drugs by Dean Ornish, Washington Post, 8-8-04
• Pharmaceutical Price Controls in OECD Countries by Kevin A. Hassett, Department of Commerce, 8-3-04
• From the analyst's couch: Statin switch to OTC by Martyn Link, Nature, 8-1-04
• Drug Dealing Washington Post, 7-31-04
• Innovative drugs cost patients less in the long run by Kerri Houston, Chicago Sun-Times, 7-31-04
• Health-care fantasies by Richard Ralston, Washington Times, 7-29-04
• Drug Industry Set Pace for Armstrong Victory by David Gratzer, Investor's Business Daily, 7-27-04
• How Tightly Do Ties Between Doctor and Drug Company Bind? by Abigail Zuger, M.D., The New York Times, 7-27-04
• Studies Show Temporary Drug Program Offers Value to Seniors by Gr